Abstract: Disclosed are novel lanthanide(III) chelates including a pyridine 4-ethynylpyrazine subunit. These chelates have an excitation wavelength which allows excitation with UV LED.
Abstract: The present disclosure relates to non-invasive diagnostics of cancers, especially breast cancer, colorectal cancer, pancreatic cancer and prostate cancer, on the basis of altered glycosylation patterns of cancer-associated biomarkers.
Type:
Application
Filed:
December 6, 2024
Publication date:
March 27, 2025
Applicant:
UNIOGEN OY
Inventors:
Kamlesh GIDWANI, Kim PETTERSSON, Henna KEKKI
Abstract: A reader device for detecting a test result from a testing element carrying a sample includes a radiation source for emitting electromagnetic radiation, an optical system for directing the electromagnetic radiation to the testing element, and a detector for receiving electromagnetic radiation from the testing element and for producing a detection signal responsive to the received electromagnetic radiation. The optical system includes a guide rod for conducting electromagnetic radiation and a lens system for focusing the electromagnetic radiation coming out via an egress-end surface of the guide rod to the testing element. The egress end-surface of the guide rod has an elongated shape so that a radiation pattern having an elongated shape is produced on the testing element. The elongated shape of the radiation pattern facilitates scanning the testing element with the electromagnetic radiation.
Abstract: The present disclosure relates to non-invasive diagnostics of cancers, such as breast cancer, colorectal cancer, pancreatic cancer and prostate cancer, on the basis of altered glycosylation patterns of cancer-associated biomarkers.
Type:
Grant
Filed:
July 14, 2017
Date of Patent:
January 14, 2025
Assignee:
UNIOGEN OY
Inventors:
Kamlesh Gidwani, Kim Pettersson, Henna Kekki